Back to search

United States· US:17089-501_bb2217fc-c752-20b1-e053-2995a90a2562

GUNA FEMALE SUPPORT

A medicinal product containing lilium lancifolium whole flowering; sus scrofa ovary; sepia officinalis juice; adenosine cyclic phosphate; sus scrofa pituitary gland; sus scrofa hypothalamus; sus scrofa adrenal gland; sus scrofa pancreas; magnesium phosphate, dibasic trihydrate; pulsatilla vulgaris, registered in United States by Guna spa.

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedGUNA FEMALE SUPPORTATC—REGISTER NO.US:17089-501_bb2217fc…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
LILIUM LANCIFOLIUM WHOLE FLOWERING; SUS SCROFA OVARY; SEPIA OFFICINALIS JUICE; ADENOSINE CYCLIC PHOSPHATE; SUS SCROFA PITUITARY GLAND; SUS SCROFA HYPOTHALAMUS; SUS SCROFA ADRENAL GLAND; SUS SCROFA PANCREAS; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PULSATILLA VULGARIS
Manufacturer
Guna spa
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    1708950118
    1 BOTTLE, DROPPER in 1 BOX (17089-501-18) / 30 mL in 1 BOTTLE, DROPPER
  • ndc11
    17089-501-18

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8ec11839-0e9a-46e8-812c-141d2ed11464
GET /v1/drugs/8ec11839-0e9a-46e8-812c-141d2ed11464?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "6; 6; 10; 6; 30; 30; 30; 30; 10; 8",
  "substance": "LILIUM LANCIFOLIUM WHOLE FLOWERING; SUS SCROFA OVARY; SEPIA OFFICINALIS JUICE; ADENOSINE CYCLIC PHOSPHATE; SUS SCROFA PITUITARY GLAND; SUS SCROFA HYPOTHALAMUS; SUS SCROFA ADRENAL GLAND; SUS SCROFA PANCREAS; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PULSATILLA VULGARIS",
  "productndc": "17089-501",
  "dosage_form": "SOLUTION/ DROPS",
  "dea_schedule": null,
  "strength_unit": "[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL",
  "application_number": null,
  "marketing_category": "UNAPPROVED HOMEOPATHIC"
}

See everything about lilium lancifolium whole flowering; sus scrofa ovary; sepia officinalis juice; adenosine cyclic phosphate; sus scrofa pituitary gland; sus scrofa hypothalamus; sus scrofa adrenal gland; sus scrofa pancreas; magnesium phosphate, dibasic trihydrate; pulsatilla vulgaris.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.